宫颈癌放疗野内及野外界骨矿物质测量值的纵向变化
该研究为前瞻性研究的二次分析,纳入2008至2015年单中心78例接受根治性放疗或放化疗的宫颈癌患者,比较放疗野内(L4)与野外(L1)骨密度变化。结果显示所有腰椎椎体骨密度随时间显著下降(P<.05),野内L4谷值在3个月,野外L1谷值在1年;3个月和2年时L4骨密度改善(P=.037),L1无差异。作者认为除放疗外,治疗及患者相关因素可能参与骨密度下降,常规骨密度筛查和放疗后激素治疗可能对部分患者有益。
要点
- 78例宫颈癌患者放疗后所有腰椎椎体骨密度随时间显著下降(P<.05)。
- 野内L4骨密度谷值在3个月,野外L1谷值在1年,野内椎体达谷值更早。
- 3个月和2年时L4骨密度改善(P=.037),L1无差异。
核心结论
- 放疗后所有腰椎椎体骨密度立即出现显著下降,但野内椎体较野外椎体更早达到骨密度谷值。
- 结果提示除放疗外,治疗及患者相关因素可能参与宫颈癌治疗后骨密度下降。
- 常规骨密度筛查和放疗后激素治疗可能对接受放化疗的特定宫颈癌患者有益(作者建议)。
研究设计与样本
- 前瞻性研究的二次分析,纳入2008至2015年单中心78例接受根治性放疗或放化疗的宫颈癌患者,分析系列CT和双能X线吸收法扫描。
- 测量L1、L2、L3、L4骨密度,比较放疗野内(L4)与野外(L1)骨密度变化,并使用线性混合模型分析放疗对骨密度随时间变化的影响及协变量校正。
主要发现
- 78例患者中位年龄45.5岁(范围23-88岁),全部接受放疗,76例(97%)接受同步放化疗。
- 治疗与所有4个腰椎椎体骨密度随时间显著下降相关(P<.05),L4谷值在3个月,L1谷值在1年。
- 治疗后3个月和2年配对比较显示,野内L4骨密度改善(P=.037),野外L1骨密度在3个月和2年时无差异。
临床怎么用
- 作者认为,常规骨密度筛查和放疗后激素治疗可能对接受放化疗的特定宫颈癌患者有益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We compared the magnitude of changes in bone mineral density (BMD), within and outside the radiation field, among women who received pelvic radiation therapy (RT) with or without chemotherapy for cervical cancer. METHODS AND MATERIALS: In this secondary analysis of a prospective study, we analyzed serial computed tomography scans and dual-energy x-ray absorptiometry scans from 78 patients who received definitive RT or chemoradiation therapy (CRT) for cervical cancer at a single institution from 2008 to 2015. BMD values at L1, L2, L3, and L4 were measured. We compared changes in BMD within the radiation field (ie, at L4) with those outside the field (ie, at L1). Linear mixed models were also used to examine the effect of RT on changes in BMD over time and covariate adjustment. RESULTS: The median age of the 78 patients was 45.5 years (range, 23-88 years); all received RT and 76 (97%) received concurrent CRT. Treatment was associated with significant declines in BMD in all 4 lumbar vertebral bodies over time (P < .05), with nadir at 3 months for L4 and at 1 year for L1. Pairwise comparisons at 3 months and 2 years after treatment indicated that BMD in L4 (within the RT field) had improved (P = .037), but BMD in L1 (outside the RT field) was no different at 3 months and 2 years. CONCLUSIONS: Significant BMD declines were observed in all lumbar vertebral bodies immediately after RT. However, in-field vertebral bodies reached nadir BMD earlier than those located outside the RT field. Our results suggest that treatment and patient-related factors other than RT may contribute to declines in BMD after treatment for cervical cancer. Routine bone density screening and post-RT therapy with hormones may be beneficial for selected patients who receive CRT for cervical cancer.
引用
- Wu J, Lakomy DS, Fellman BM, et al. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol. 2022. PMID: 35390531. doi:10.1016/j.prro.2022.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。